The easiest to treat patients are those who have not been ill too long, who don’t have a lot of complicating conditions, who have become depressed at a time in their life where there are clear cut, stressful factors, and who have ample social support, explained Michael Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.
The easiest to treat patients are those who have not been ill too long, who don’t have a lot of complicating conditions, who have become depressed at a time in their life where there are clear cut, stressful factors, and who have ample social support, explained Michael Thase, MD, professor of psychiatry and director of the Mood and Anxiety Program at the University of Pennsylvania.
TranscriptAre there patient characteristics or biomarkers that guide treatment protocol for patients with major depressive disorder?
The easiest to treat patients are the ones who have not been ill too long, who don’t have a lot of complicating conditions, who have become depressed at a time in their life where there are clear cut, stressful factors, and who have ample social support, and these folks have good prognoses, they have good prognostic disorders. The earlier the illness takes hold in life, the more complicating conditions you’re likely to have, the less likely you are to have acquired a family and a good job and a good insurance plan, and the things that go along with having a good prognosis.
So, these king of early onset chronicity and complexity go along with people who definitely need more intensive treatment plans—psychotherapy as well as pharmacotherapy, sometimes occupational or vocational assistance and rehabilitation. One thing Freud got right is that love and work are the kind of cornerstones to human well-being, and depression is an illness that can reduce your capacity to be sustained in love relationships and to be able to work effectively.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More